New directions in the design of phenylboronate-functionalized polymers for diagnostic and therapeutic applications

36Citations
Citations of this article
39Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Phenylboronic acid (PBA) derivatives, which are often termed 'boronolectins,' are regarded as a synthetic mimic of lectins because of their ability to interact with various carbohydrates. This unique chemistry has already borne fruit as the molecular bases for glucose sensors and some bio-separation applications. This focus review highlights some of the emerging PBA-based research directions toward more versatile diagnostic and therapeutic targets, which the authors are currently pursuing. The topics reviewed include PBA-mediated targeting to sialic acid (SA) as a methodology relevant to tumor diagnosis and treatment. Other drug delivery systems, including those for siRNA and insulin, in which PBA has a unique role in physicochemical signal transduction, will also be summarized. © 2014 The Society of Polymer Science, Japan (SPSJ). All rights reserved.

Cite

CITATION STYLE

APA

Matsumoto, A., Kataoka, K., & Miyahara, Y. (2014). New directions in the design of phenylboronate-functionalized polymers for diagnostic and therapeutic applications. Polymer Journal. Nature Publishing Group. https://doi.org/10.1038/pj.2014.42

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free